||Sector: Health care
||ISIN Code: INE107F01022
00:00 | 24 Apr
05:30 | 01 Jan
Board Meeting Intimation for Sub.: Notice Of Board Meeting For Approving The Standalone & Consolida
February 5, 2020, 11:46 am | Source: BSE
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2020 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of Wanbury Limited is scheduled to be held on Friday 14th February 2020 at Mumbai inter-alia to consider and approve the Un-audited Standalone & Consolidated Financial Results (UFR) for the third quarter and nine months ended 31st December 2019.
Further the trading window in respect of the Companys Securities shall remain closed for all Directors / Officers / Designated Employees of the Company from 1st January 2020 till 16th February 2020 as per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.
Kindly take the same on your records and acknowledge the receipt.